Nothing Special   »   [go: up one dir, main page]

Byfield et al., 1976 - Google Patents

Murine neuroblastoma cured in vivo by an antibody-dependent cellular cytotoxicity reaction

Byfield et al., 1976

Document ID
862840711806301388
Author
Byfield J
ZERUBAVEL R
FONKALSRUD E
Publication year
Publication venue
Nature

External Links

Snippet

CYTOLYSIS of antibody-coated tumour cells mediated by reticuloendothelial (RE) or bone marrow cells is a phenomenon of unknown biological relevance1–4. The specificity of the reaction lies in the antibody5, 6; probably most or all cells able to recognise the Fc fragment …
Continue reading at www.nature.com (other versions)

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/30—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/0005—Vertebrate antigens
    • A61K39/0011—Cancer antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation; Therapies using these preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/827—Proteins from mammals or birds
    • Y10S530/828—Cancer

Similar Documents

Publication Publication Date Title
Lee et al. Autologous leukemia-specific T-cell-mediated lymphocytotoxicity in patients with acute myelogenous leukemia.
Bale et al. Studies directed toward the use of antibodies as carriers of radioactivity for therapy
Basten et al. A receptor for antibody on B lymphocytes: I. Method of detection and functional significance
Apuzzo et al. Immunological aspects of intrinsic glial tumors
US5635188A (en) Anti-cancer vaccine
JP3478398B2 (en) Immunostimulatory monoclonal antibodies
Vanky et al. Serum-mediated inhibition of lymphocyte stimulation by autochthonous human tumors
Hellström et al. Immunologie Defenses Against Cancer
Cheever et al. Tumor neutralization, immunotherapy, and chemoimmunotherapy of a Friend leukemia with cells secondarily sensitized in vitro
Bblomgren et al. Effect of radiotherapy on blood lymphocyte population in mammary carcinoma
JPH06205671A (en) Extraction and cultivation of transformed cell and preparation of antibody thereagainst
Peter et al. Humoral and cellular immune reactions' in vitro'against allogeneic and autologous human melanoma cells.
Horn et al. An immunological approach to the therapy of cancer?
Tomasi Jr Serum factors which suppress the immune response
Badger et al. Immunosuppressive activity of ascitic fluid from patients with cancer metastatic to the peritoneum
Ghebrehiwet et al. Potentiation of antibody-dependent cell-mediated cytotoxicity by target cell-bound C3b
Byfield et al. Murine neuroblastoma cured in vivo by an antibody-dependent cellular cytotoxicity reaction
Han et al. In vitro preferential effect of irradiation on cultured T lymphoid cell line
Glaser Indomethacin‐sensitive suppressor cells regulate the cell‐mediated cytotoxic response to SV 40‐induced tumor‐associated antigens in mice
JPH0734742B2 (en) Hybridoma cells producing monoclonal antibody capable of lysing human NK cells
HELLSTRÖM et al. The role of cell-mediated immunity in control and growth of tumors
La Via et al. Studies on Fc receptor function: I. IgG-mediated inhibition of B lymphocyte activation by T-dependent and T-independent antigens
DISAIA et al. Antibody cytotoxicity studies in ovarian and cervical malignancies
Hanna et al. Normal immunosuppressive protein: inhibitory effect on immune response against tumour cells.
Sato et al. Human immune response to DNP-modified autologous cells after treatment with a DNP-conjugated melanoma vaccine